Visual Rating of Age-Related White Matter Changes on Magnetic Resonance Imaging: Scale Comparison, Interrater Agreement, and Correlations With Quantitative Measurements

Background and Purpose— To provide further insight into the MRI assessment of age-related white matter changes (ARWMCs) with visual rating scales, 3 raters with different levels of experience tested the interrater agreement and comparability of 3 widely used rating scales in a cross-sectional and follow-up setting. Furthermore, the correlation between visual ratings and quantitative volumetric measurement was assessed. Methods— Three raters from different sites using 3 established rating scales (Manolio, Fazekas and Schmidt, Scheltens) evaluated 74 baseline and follow-up scans from 5 European centers. One investigator also rated baseline scans in a set of 255 participants of the Austrian Stroke Prevention Study (ASPS) and measured the volume of ARWMCs. Results— The interrater agreement for the baseline investigation was fair to good for all scales (&kgr; values, 0.59 to 0.78). On the follow-up scans, all 3 raters depicted significant ARWMC progression; however, the direct interrater agreement for this task was poor (&kgr;, 0.19 to 0.39). Comparison of the interrater reliability between the 3 scales revealed a statistical significant difference between the scale of Manolio and that of Fazekas and Schmidt for the baseline investigation (z value, −2.9676;P =0.003), demonstrating better interrater agreement for the Fazekas and Schmidt scale. The rating results obtained with all 3 scales were highly correlated with each other (Spearman rank correlation, 0.712 to 0.806;P ≤0.01), and there was significant agreement between all 3 visual rating scales and the quantitative volumetric measurement of ARWMC (Kendall W, 0.37, 0.48, and 0.57;P <0.001). Conclusions— Our data demonstrate that the 3 rating scales studied reflect the actual volume of ARWMCs well. The 2 scales that provide more detailed information on ARWMCs seemed preferential compared with the 1 that yields more global information. The visual assessment of ARWMC progression remains problematic and may require modifications or extensions of existing rating scales.

[1]  F. Fazekas,et al.  Evolution of White Matter Lesions , 2002, Cerebrovascular Diseases.

[2]  P. Scheltens,et al.  A New Rating Scale for Age-Related White Matter Changes Applicable to MRI and CT , 2001, Stroke.

[3]  F. Fazekas,et al.  MRI white matter hyperintensities , 1999, Neurology.

[4]  P. Scheltens,et al.  Progression of cerebral white matter hyperintensities on MRI is related to diastolic blood pressure , 1998, Neurology.

[5]  O Salonen,et al.  Variable agreement between visual rating scales for white matter hyperintensities on MRI. Comparison of 13 rating scales in a poststroke cohort. , 1997, Stroke.

[6]  F. Fazekas,et al.  [Prevalence and risk factors in the population of Graz (Austrian Stroke Prevention Study)]. , 1997, Wiener medizinische Wochenschrift.

[7]  H. Reichmann,et al.  Distal muscular dystrophy of Miyoshi type , 1996, Journal of Neurology.

[8]  F. Fazekas,et al.  The relation of cerebral magnetic resonance signal hyperintensities to Alzheimer's disease , 1996, Journal of the Neurological Sciences.

[9]  P Kapeller,et al.  Magnetic resonance imaging correlates of transient cerebral ischemic attacks. , 1996, Stroke.

[10]  F. Fazekas,et al.  MR of cerebral abnormalities concomitant with primary intracerebral hematomas. , 1996, AJNR. American journal of neuroradiology.

[11]  F. Fazekas,et al.  Anticardiolipin antibodies in normal subjects. Neuropsychological correlates and MRI findings. , 1995, Stroke.

[12]  F. Barkhof,et al.  Histopathologic correlates of white matter changes on MRI in Alzheimer's disease and normal aging , 1995, Neurology.

[13]  E P Steinberg,et al.  Magnetic resonance abnormalities and cardiovascular disease in older adults. The Cardiovascular Health Study. , 1994, Stroke.

[14]  F. Fazekas,et al.  Neuropsychologic correlates of MRI white matter hyperintensities , 1993, Neurology.

[15]  F. Fazekas,et al.  Pathologic correlates of incidental MRI white matter signal hyperintensities , 1993, Neurology.

[16]  P. Scheltens,et al.  A semiquantative rating scale for the assessment of signal hyperintensities on magnetic resonance imaging , 1993, Journal of the Neurological Sciences.

[17]  F. Fazekas,et al.  Magnetic resonance imaging signal hyperintensities in the deep and subcortical white matter. A comparative study between stroke patients and normal volunteers. , 1992, Archives of neurology.

[18]  F. Fazekas,et al.  The Prevalence of Cerebral Damage Varies With Migraine Type: A MRI Study , 1992, Headache.

[19]  F. Fazekas,et al.  Prevalence of White Matter and Periventricular Magnetic Resonance Hyperintensities in Asymptomatic Volunteers , 1991 .

[20]  D. Leys,et al.  Periventricular and white matter magnetic resonance imaging hyperintensities do not differ between Alzheimer's disease and normal aging. , 1990, Archives of neurology.

[21]  M. Rothberg,et al.  Lyme disease of the CNS: MR imaging findings in 14 cases. , 1990, AJNR. American journal of neuroradiology.

[22]  A. Alavi,et al.  MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. , 1987, AJR. American journal of roentgenology.

[23]  W. Bradley Patchy, periventricular white matter lesions in the elderly : common observation during NMR imaging , 1984 .

[24]  Rater agreement for complex assessments , 1983 .

[25]  P M Moodie,et al.  COHORT , 1971, The Medical journal of Australia.

[26]  J. Fleiss Measuring nominal scale agreement among many raters. , 1971 .